Compounds > valdecoxib
Page last updated: 2024-09-03

valdecoxib and Allodynia

valdecoxib has been researched along with Allodynia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischer, J; Gyires, K; Kis-Varga, A; Szabó, G1
Czugler, M; Erdélyi, P; Fischer, J; Fodor, T; Gere, A; Varga, AK1
Bevan, S; Courade, JP; Dawson, J; Fox, A; Glatt, M; Gonzalez, I; Medhurst, S; Urban, L1
Gierse, JK; Hood, WF; Isakson, PC; Koboldt, CM; Masferrer, JL; Maziasz, TJ; Muhammad, JL; Seibert, K; Trigg, JS; Walker, MC; Zhang, Y; Zweifel, BS1
Ilavarasan, R; Kesavanarayanan, KS; Nappinnai, M1

Other Studies

5 other study(ies) available for valdecoxib and Allodynia

ArticleYear
New celecoxib derivatives as anti-inflammatory agents.
    Journal of medicinal chemistry, 2008, Jan-10, Volume: 51, Issue:1

    Topics: Acetic Acid; Animals; Carrageenan; Celecoxib; Chronic Disease; Crystallization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Edema; Ethanol; Gastric Mucosa; Hyperalgesia; Male; Pyrazoles; Rats; Rats, Wistar; Recombinant Proteins; Stereoisomerism; Stomach Ulcer; Sulfonamides

2008
Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib.
    Bioorganic & medicinal chemistry, 2008, May-01, Volume: 16, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Humans; Hyperalgesia; Inflammation; Isoxazoles; Male; Models, Molecular; Molecular Structure; Pain; Pain Measurement; Rabbits; Rats; Rats, Wistar; Recombinant Proteins; Stereoisomerism; Sulfonamides; Time Factors

2008
Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat.
    Pain, 2004, Volume: 107, Issue:1-2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Bone Density; Bone Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Hyperalgesia; Inflammation; Isoenzymes; Isoxazoles; Organic Chemicals; Pain; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Radiology; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Tumor Cells, Cultured

2004
Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Hyperalgesia; Inflammation; Isoxazoles; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Sulfonamides

2005
Topical dosage form of valdecoxib: preparation and pharmacological evaluation.
    Acta pharmaceutica (Zagreb, Croatia), 2007, Volume: 57, Issue:2

    Topics: Acrylic Resins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation, Preclinical; Drug Stability; Edema; Gels; Hindlimb; Hydrogen-Ion Concentration; Hyperalgesia; Isoxazoles; Male; Ointments; Pain Measurement; Rats; Rats, Wistar; Skin Irritancy Tests; Sulfonamides; Surface Properties; Time Factors; Treatment Outcome

2007